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Abstract: It has been reported that Spirulina maxima and other natural products are effective in attenuating hepatic damage. In this study 
were analyzed the effects of five days dietary Spirulina platensis (5%) in rats with fatty liver induced by CCl4 (2 mL/kg b.w.). Animals were 
sacrificed at 24 and 48 h post-treatment. In the liver were evaluated total lipids by gravimetry and lipid profile by enzymatic-colorimetric 
methods, the concentration of thiobarbituric acid reactive substances and nitric oxide by chemical methods. In serum, alanine 
aminotransferase (kinetic method) and lipid profile were evaluated. The most important effects on the liver were: attenuation in lipid 
peroxidation, minimal variations on the total fatty acid methyl esters profile, and nitric oxide. These results suggest that Spirulina platensis 
could be used for fatty liver treatment as an alimentary supplement. 
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Resumen: Se ha reportado que la Spirulina maxima y otros productos naturales son efectivos para atenuar el daño hepático. El objetivo del 
presente estudio fue evaluar los efectos de la Spirulina platensis dietaria (5%) durante cinco días en ratas con hígado graso inducido por 
CCl4 (2 mL/kg p.c.). Los animales fueron sacrificados a las 24 y 48 h postratamiento. En el hígado se evaluaron los lípidos totales por 
gravimetría y el perfil de lípidos por métodos enzimático-colorimétricos, la concentración de sustancias reactivas al ácido tiobarbitúrico y 
óxido nítrico por métodos químicos. En suero fueron evaluados alanina aminotransferasa (método cinético) y perfil de lípidos. Los 
principales efectos sobre el hígado fueron: la atenuación de la lipoperoxidación, variaciones mínimas en el perfil de metil ésteres de ácidos 
grasos totales y del óxido nítrico. Estos resultados sugieren que la Spirulina platensis podría ser utilizada como suplemento alimenticio en el 
tratamiento de hígado graso. 
 
Palabras clave: TBARS, antioxidantes, triacilgliceroles, óxido nítrico, cianobacteria y lípidos. 
 
 
 
 
Recibido | Received: March 22, 2013 
Aceptado en versión corregida | Accepted in revised form: June 9, 2013 
Publicado en línea | Published online: March 30, 2014 
Declaración de intereses | Declaration of interests: The authors acknowledge the grant IN-205410 from UNAM-DGAPA-PAPIIT. 
Este artículo puede ser citado como / This article must be cited as: PV Torres-Duran, A Ferreira-Hermosillo, A Ramos-Jiménez, RP Hernández-Torres, MC Paredes-Carbajal, 
MA Juarez-Oropeza. 2014. Protective effect of Spirulina platensis on fatty liver induced by a single sublethal dose of carbon tetrachloride in wistar rats. Bol Latinoam Caribe 
Plant Med Aromat 13(2): 178 – 188.  
Torres-Duran et al.  Spirulina platensis  effects on fatty liver 
 
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/179 
 
LIST OF ABBREVIATIONS 
ALT: Alanine aminotransferase; AOAC: Asociation of 
Official Analytical Chemists; BHT:  Butylated 
hydroxytoluene; CCl4:  carbon tetrachloride; FAMEs: 
Fatty acids methyl esters; GC-MS: Gas 
chromatography-mass spectroscopy; NAFLD:  
Nonalcoholic fatty liver disease; NASH: non-alcoholic 
steatohepatitis; NO: Nitric oxide; Sp: Spirulina 
platensis; Sm: Spirulina maxima; TAG: 
Triacylglycerols; TBA: Thiobarbituric Acid; 
TBARs:Thiobarbituric acid reactive substances. 
 
INTRODUCTION   
Nonalcoholic fatty liver disease (NAFLD) includes a 
group of diseases ranging from hepatic steatosis until 
cirrhosis and liver failure (Obika and Noguchi, 2012). 
Nowadays it is recognized as a metabolic disorder 
characterized by fatty accumulation in the liver 
without alcohol consumption and it has been linked to 
metabolic syndrome (consisting of central obesity, 
hyperglycemia, dyslipidemia and hypertension) 
(Bogdanova et al., 2006; Cho, 2011). Although, the 
pathogenesis of non-alcoholic steatohepatitis (NASH) 
is multifactorial (Rolo et al., 2012), strong evidence 
from human and animal models indicates that 
inflammatory activation clearly plays a pivotal role in 
the progression of this disease (Braunersreuther et al., 
2012; Farrell et al., 2012). Other proposed 
mechanisms in NAFLD pathophysiology include: 
increased oxidative stress, cytokine production, 
lipotoxicity and autoimmunity (Otogawa et al., 2007; 
Anderson and Borlak, 2008; Fon Tacer and Rozman, 
2011; Rolo et al., 2012).  
Although isolated fatty liver is thought to have 
a relatively benign natural history in reference to 
histopathologic progression of disease, NASH may 
progress to cirrhosis and finally to liver failure (Mirza, 
2011). There are not sufficient epidemiological data 
about the prevalence of NAFLD in Mexico even liver 
diseases are leading causes of death in this country 
(Ferreira-Hermosillo et al., 2010) .Therefore, effective 
treatments are needed.  
Among others, weight reduction, 
ursodeoxycholic acid, vitamin E, metformin, and 
betaine have been used as modalities of treatment, 
none of them are totally effective (Akcam et al., 2011; 
Mukherjee, 2011; Ratziu et al., 2011; Caporaso et al., 
2012; Enjoji et al., 2012; Farrell et al., 2012; 
Shargorodsky et al., 2012).
 
 
Natural products are growing up as an 
alternative treatment for hyperlipidemia, obesity and 
metabolic syndrome, since its minimal side effects and 
multiple ways to control lipid metabolism (Sakane, 
2011; Molloy et al., 2012; Park et al., 2012). It has 
been demonstrated that Spirulina maxima (Sm) is 
effective in to ameliorate NAFLD induced by CCl4 in 
animals (Torres-Duran et al., 2006), and NASH in 
human beings (Ferreira-Hermosillo et al., 2010), 
mainly due to its hypolipidemic (Torres-Duran et al., 
2007) and antioxidant properties (Ponce-
Canchihuaman et al., 2010).  
Spirulina platensis (Sp) is a cyanobacterium, 
which grows naturally in alkaline lakes. Because of 
their high content of protein (60-70%), high 
concentration of essential aminoacids, and other 
nutritional elements, including B complex vitamins, 
vitamin E, manganese, zinc, copper, iron and selenium 
(Chamorro et al., 2002; Torres-Duran et al., 2007) Sm 
and Sp have been grown on non-natural conditions for 
production of commercial food supplements. Sm and 
Sp are excellent food supplements, recently assigned 
as a class A product by the Dietary Supplements 
Information Expert Committee (DSI-EC) of the United 
States Pharmacopeial Convention (USP) (Marles et 
al., 2011). 
It has been demonstrated that Sp is an 
important candidate for Se enrichment (Kravchenko et 
al., 2008). Also, it was reported that Sp is a promising 
source for dietary Se supplementation (Kravchenko et 
al., 2008). Furthermore, Sp is an important source of 
pigments like β-carotene and other carotenoids, 
phycocyanine and chlorophyll (Jassey et al., 1971; 
Ciferri, 1983). Sp has essential fatty acids like ω-3 and 
ω-6 fatty acids (Colla et al., 2004); precursors of 
important metabolites like prostaglandins and 
leukotrienes.  
Sp and Sm have several biological effects such 
as hypocholesterolemic effects, decreased cancer risk 
(Nakaya et al., 1988; Byers, 1992), and an attenuation 
of fatty liver in experimental models (Torres-Duran et 
al., 1998; Torres-Duran et al., 2006) and clinically 
assessed in humans (Ferreira-Hermosillo et al., 2010). 
The aim of this study was to analyze the 
potential effects of Sp supplementation to decrease 
liver lipoperoxidation induced by CCl4. It was 
measured lipid profile and fatty acid composition in 
the injured rat liver with the purpose to elucidate the 
possible mechanisms involved in the NAFLD 
development.  
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MATERIALS AND METHODS 
Chemicals and reagents  
The spray-dried powder of Sp was purchased from 
Genix (Empresa de producción y comercialización de 
microalgas y sus derivados; La Habana, Cuba). 
Purified diet AIN-76a (American Institute of Nutrition 
-76a) was purchased from ICN Pharmaceuticals 
(Mexico). Carbon tetrachloride, organic solvents and 
typical reagents were purchased from Merck 
(Mexico). Thiobarbituric Acid (TBA) was purchased 
from Sigma (St. Louis, MO). Cholesterol and 
triacylglycerols were measured using commercial 
enzymatic-colorimetric kits purchased from Jas 
(Mexico). Alanine aminotransferase activity kits 
(ALT) were purchased from Jas (Mexico). 
 
Proximate analysis of Sp 
A sample of Sp was analyzed by proximate analysis 
methods according to the Association of Official 
Analytical Chemists (AOAC): moisture, ether extract, 
protein, carbohydrates, crude fiber and ash. In 
addition, total lipids were extracted with Folch solvent 
(chloroform/methanol, 3:1, v/v). 
 
 
Animals and treatments 
Sixty male Wistar rats, weighing 190 - 250 g 
(purchased and bred in the Animal Care and Breeding 
Unit of the Facultad de Medicina, UNAM, Mexico 
City), were randomly allocated in two groups 
according to their diet: Control Group (control purified 
AIN-76a diet without Sp) and Sp group (experimental 
purified diet, AIN-76a diet with 5% Sp) according to 
previously dose used with Sm (Gonzalez de Rivera et 
al., 1993). 
The distribution of the groups according to the 
diet and treatment is shown in Table 1. 
Animals were housed (groups of 2 or 3 rats 
per cage) in a room with controlled temperature (20 - 
25° C) and light exposure (07:00 - 19:00 h) for five 
days before CCl4 or vehicle (corn oil) treatment. The 
rats were fed on AIN-76 a diet (20 g of purified 
diet/day/per rat) with or without Sp throughout the 
experimental period. Water was provided ad libitum.  
On fifth day of feeding respective diet, 
animals (12 h fasting) were treated either with a single 
intraperitoneal injection of CCl4, 2 mL/kg of body 
weight with corn oil as vehicle (1:1, v/v) to induce 
fatty liver (Torres-Duran et al., 2006). Afterwards, 24 
or 48 h after treatment, the animals were killed by 
cervical dislocation, after have been anesthetized with 
diethylether, this procedure according to the “Guiding 
Principles in the Use of Animals in toxicology”: 
 
Table 1 
Experimental design and distribution of the groups 
Diet/time after 
treatment 
0 h 24 h 48 h 
AIN  Control Control CCl4 Control CCl4 
AIN+ 5% Sp Control + Sp Control + Sp CCl4 + Sp Control + Sp CCl4 + Sp 
 
Diet was provided throughout the 
experimental period (5 days pre-treatment plus 1 or 2 
days after treatment). Control groups at 24 and 48 h 
were treated with the vehicle. The animals were 
conformed in ten groups with six rats each one. 
 Serum was obtained from blood centrifugation 
and stored at -78º C until use. Livers were carefully 
excised, weighed and stored at -78º C, adding 0.025 % 
of butylated hydroxytoluene (BHT) as antioxidant, 
until lipid analyses were performed.  
 
Ethical statement 
All procedures were performed in strictly observing 
the international (Animal Research: Reporting In Vivo 
Experimental, ARRIVE guidelines) (Kilkenny et al., 
2012) and national guidelines for care and use of 
experimental animals (Laboratory Animals and 
Official Mexican Norms, NOM-062-ZOO-1999) (de 
Aluja, 2002). The project was evaluated and approved 
(registration project number 111-2008) by the Ethical 
and Research Commission, a dependence of Research 
Coordination of Facultad de Medicina, UNAM.   
 
Liver total lipids  
Total lipids were extracted with chloroform-methanol 
by a modified version of Folch´s method (Folch et al., 
1957). For liver samples, 1 g of tissue was 
homogenized in 4 volumes of 0.05 M phosphate 
buffer, pH 7.2. Then, pH was adjusted to 6.0 by 
addition of HCl. This suspension was extracted three 
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times with 20 volumes of chloroform/methanol (3:1, 
v/v) each. The extract was washed with 10 mL of 
water; the organic fraction was evaporated under a 
nitrogen stream, then analytically weighed 
(gravimetric method), and stored at -78º C until total 
cholesterol, triacylglycerols (TAG), thiobarbituric acid 
reactive substances (TBARs), and gas 
chromatography-mass spectroscopy (GC-MS) of fatty 
acid methyl esters (FAMEs) analyses were performed.  
 
Lipid peroxidation 
Analysis was performed on total lipids according to 
TBARs reaction, a previous technique performed in 
our laboratory (Torres-Duran et al., 1998). 
 
Nitric Oxide Production 
The nitric oxide (NO) production was assayed 
measuring its stable derivative, nitrites. Samples of 
each liver (24 h CCl4 groups, with or without Sp) were 
homogenized (1 g wet weight) by duplicate in 4 
volumes of deionized water. Proteins in the 
homogenate were precipitated using 0.1 volume 28% 
trichloroacetic acid, mixed vigorously during 1 
minute, after 10 min they were centrifuged at 8,000 x 
g during 8 min. The supernatant was adjusted at pH 
7.0, then lyophilized and was 2.5 times concentrated 
from the original volume. Nitrites were analyzed as 
recommended by the supplier (ROCHE, Mexico). 
Briefly, nitrates were reduced by nitrate reductase in 
presence of non-limiting concentrations of NADPH 
and FAD incubated at 37º C during 30 min. The 
Griess reactive was added to the sample and incubated 
at 37º C during 10 min. The sample absorbance was 
read at 540 nm. The developed color was stable at 
least 1h at room temperature. Concentration of NO 
derivatives (nitrites) was normalized by protein 
content. The total protein concentration was performed 
in aliquots of the homogenate, using the Lowry 
method (Lowry et al., 1951). 
 
Determination of serum and liver lipids  
Serum and liver contents of TAG and TC were 
measured using commercial enzymatic-colorimetric 
kits (Jas, México).  
 
Determination of serum ALT 
Serum ALT enzyme activity was measured using 
commercial kits (Jas, México).  
 
Fatty acids methyl esters (FAMEs) 
Fatty acid methyl esters from liver lipids were 
prepared with anhydrous methanol using a concentrate 
of sulfuric acid, and recovered in hexane, as reported 
previously (Torres-Duran et al., 2006). 
 
Gas chromatography-mass spectrometry analysis 
We used GC-MS for specific determination of  
FAMEs, as previously described (Torres-Duran et al., 
2006). For each liver an aliquot of lipid extract was 
analyzed by gas chromatography in a Hewlett Packard 
(HP 5890) gas chromatograph coupled to a mass 
selective detector (HP model 5972).  
 
Statistical analysis 
Results were evaluated by ANOVA for multiple 
comparison tests with a post hoc Tuckey test, 
according to data distribution using SPSS version 17.0 
as statistical package. A p value of 0.05 or lower was 
considered significant.  
 
RESULTS  
The proximate analysis of Sp showed the following 
values, expressed as % dry base: 60% protein, 9% ash, 
17% carbohydrates (including 3.2% crude fiber), and 
14% total lipids extracted with chloroform/methanol 
(3:1, v/v), where 1.8% of total lipids were neutral 
lipids (diethyl ether extract).  
In the present study, it was tested the 
hepatoprotective effects of Sp against oxidative stress 
on acute liver injury induced by CCl4 in rats. 
Administration of CCl4 to rats caused severe hepatic 
damage, as demonstrated by the significant increase of 
ALT activity in serum at 24 and 48 h post CCl4 
treatment (Figure 1); however, at 48 h a significant 
attenuation in rats fed on Sp was observed compared 
to rats fed without Sp (p < 0.01). 
Total lipids from the liver showed an 
increasing trend in groups treated with CCl4; however 
the differences were not significant.  
After CCl4 treatment, as expected, liver 
content of triacylglycerols was increased in both 
groups (Figure 2A); however, these lipids were 
significantly lower at 48 h in rats fed on Sp diet than in 
rats without Sp in their diet. In a similar way, the 
serum TAG values were higher at 48 h in both treated 
groups compared with the control group (Figure 2B), 
which coincides with the induction of fatty liver, as 
well as with the increase of ALT activity (Figure 1). 
Furthermore, in animals that were not treated with 
CCl4, the serum TAG concentration was significantly 
lower in rats fed on Sp diet than in animals without Sp 
in their diet (Figure 2B).  
On the other hand, liver total cholesterol 
content was decreased at 24 h post-treatment, 
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returning to the basal values at 48 h (Figure 2C). 
These findings were not associated with the serum TC 
since there were no significant changes vs. their 
respective control groups, although the cholesterol 
value was lower in the groups fed on Sp diet (75 ± 
19.6 mg/dL) than in the groups fed on diet without Sp 
(99 ± 16.5 mg/dL), (n = 15, p < 0.01). 
In addition, the liver levels of oxidative stress 
indicators after CCl4 treatment were increased in the 
animals fed on diet without Sp (Figure 3). TBARs 
levels increased at 24 h and 48 h in groups fed without 
Sp (Figure 3A). In contrast, its concentration did not 
change in rats fed on 5% Sp at 24 h and 48 h (p < 
0.01). As for nitric oxide production (Figure 3B), the 
results showed that the control groups had values 
between 2.5 and 5,0 nmol/mg protein (without or with 
Sp), while in the groups treated with CCl4 and fed on 
diet without Sp at 24 h showed higher concentrations 
than those in Sp-fed groups (p < 0.01). 
 
Figure 1 
Serum alanine aminotransferase activity after CCl4 treatment in rats. 
 
Values are expressed as U/L (mean ± SD of n = 6 rats). Statistical analysis was carried out with one-way 
ANOVA and Tuckey post hoc test.  Although ALT activity was significantly increased in all the CCl4 treated 
groups, the p value is omitted by simplicity. Then, the difference between Control + CCl4 vs. Sp + CCl4 
groups at 48 h is shown. 
 
 The relative abundance (%) of the unsaturated 
and saturated fatty acids in control groups without 
CCl4 treatment showed that saturated fatty acids 
explain almost 60% of the total identified FAMEs 
(16:0 > 18:0), whereas the abundance of unsaturated 
fatty acids was a little higher than 40% (18:1, 18:2, 
18:3, 20:4, were present in about the same proportion). 
After CCl4 treatment the saturated/unsaturated ratio 
was lower in animals fed on diet without Sp than those 
fed on diet with Sp, this change was in a inversed way 
than the one observed in control animals (see control 
group vs 48 h CCl4 group in Table 2). 
 
DISCUSSION  
The proximate analysis in this study showed a protein 
level lower than the one obtained in another study 
where 70% protein content was observed (Ciferri, 
1983). Other minimal differences were in ash content 
(5%), and total carbohydrates (19%) (Ciferri, 1983). 
The differences could be due to the different 
environment where Sp was cultured, since 
cyanobacteria may receive different nutrients and be 
influenced by the season of the year or inclination of 
sunlight (Ciferri, 1983). However, the values obtained 
in this study are similar to those obtained for Sm 
analysis in our study (Torres-Duran et al., 2006), 
where 60% protein content was found. Only crude 
fiber was higher in Sp than in Sm. Therefore, as 
explained for Sm, these very low values of dietary 
fiber could hardly explain the effects on lipid 
concentrations observed in the present study. 
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Figure 2 
 
 
                               
 
 
                                
Effects of Spirulina platensis on serum and liver lipids. Liver (A) and serum (B) triacylglycerol levels, as well 
as total cholesterol concentration in the liver (C) were analyzed 24 and 48 h after CCl4 treatment. Results are 
expressed as mean ± SD of n = 6 rats. Although liver TAG levels were significantly increased in all the CCl4 
treated groups, the p value is omitted by simplicity. Then, the difference between Control + CCl4 vs. Sp + 
CCl4 groups at 48 h is shown Statistical analysis was carried out with one-way ANOVA and Tuckey post hoc 
test. 
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In the present study, we have demonstrated the 
hepatoprotective effect of Sp in the liver injury 
induced by CCl4. The administration of this 
hepatotoxin causes severe acute liver damage in rats, 
as demonstrated by the significant elevation of serum 
ALT activity, similar to AST (Aspartate 
aminotransferase) elevation seen in a previous work 
(Torres-Duran et al., 2006). The hepatoprotective 
effect was similar to the one obtained using Sm 
(Torres-Duran et al., 2006). Similarly, and according 
to our results, Lu et al., (2010), demonstrated that AST 
and ALT concentration were attenuated in rats fed on 
a diet with 6% Sp after treatment with acetaminophen 
and D-galactosamine like injury liver inductors. 
Additionally, they found that MDA concentration in 
liver, IL-18 mRNA expression and IL-18 serum levels 
decreased after Sp treatment, which could mean an 
effective protection against liver injuries through a 
decrease on lipoperoxidation and inflammation. 
Studies with different Spirulina species have 
demonstrated that it has hypolipidemic activity in rats 
with and without toxic substances (Iwata et al., 1990; 
Ble-Castillo et al., 2002). In the same way, in this 
study, the main observed effects on lipids were the 
decrease of TAG in liver and a transient decrease of 
cholesterol levels in liver.  
 
Figure 3 
Effects of Spirulina platensis on liver lipoperoxidation and nitric oxide production. 
 
Thiobarbituric acid reactive substances concentration in total lipid extract (A), and Nitric oxide 
concentration in liver homogenate (B) were analyzed after CCl4 treatment. The results are expressed as 
mean ± SD of n = 6 rats. Statistical analysis was carried out with one-way ANOVA and Tuckey post hoc test. 
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After CCl4 treatment, as expected, liver 
triacylglycerols were increased in both groups; 
however, lipids were significantly lower at 48 h in rats 
fed on a diet with Sp than in rats without Sp in their 
diet. The serum TAG concentration, at 48 h, was 
increased in both treated groups compared with their 
respective control groups, which coincides with the 
induction of fatty liver. Furthermore, serum TAG 
concentration in animals fed on diet with Sp showed a 
significant decrease compared to animals fed on 
normal diet (both groups without CCl4 treatment). This 
hypolipidemic effect has been previously observed in 
rats (Torres-Duran et al., 2006), in 
hypertriglyceridemic individuals (Torres-Duran et al., 
2007), and in carriers of steatohepatitis (Ferreira-
Hermosillo, 2011). 
 On the other hand, liver total cholesterol 
concentration was decreased at 24 h, returning to the 
basal values at 48 h, but in contrast to the behavior 
observed with TAG, the cholesterol values were not 
associated to their serum levels; this observation has 
been found in other studies, in which it was attributed 
to the duration of the study because cholesterol 
clearance is slower compared to other metabolites 
(Nakaya et al., 1988) however, we are unable to 
present any other explanation. The TBARs content in 
groups treated with the hepatotoxin and fed on diet 
without Sp was significantly increased at 24 and 48 h; 
however, its concentration did not change in rats fed 
on 5% Sp. These effects are similar to those observed 
using the Sm (Torres-Duran et al., 2006) and confirm 
the hepatoprotective properties of genus Spirulina 
(Ferreira-Hermosillo et al., 2011). 
 
Table 2 
Profile of fatty acid methyl esters (FAME) in total lipids of the liver. 
 
FAME (%) 14:0 16:0 18:0 SAT 16:1 18:2a 18:1 20:4 UNSAT 
Ratio 
SAT/UNSAT 
Group  
          Control 0.46 ± 0.29 39.26 ± 16.8 23.02 ± 8.1 62.75 ± 8.4 1.82 ± 2.2 13.56 ± 6.4 11.25 ± 6.4 14.10 ± 5.0 40.73 ± 5.0  1.5 
Control + Sp 
 
34.75 ± 9.9 29.27 ± 6.4 64.03 ± 8.1 1.48 ± 1.1 25.74 ± 7.1 10.99 ± 5.2 8.62 ± 6.8 46.83 ± 5.0 1.4 
24h CCl4 1.49 ± 1.0 47.62 ± 11.2 17.40 ± 10.9 66.51 ± 7.7 1.92 ± 1.2 22.51 ± 13.0 20.16 ± 17.2 3.20 ± 1.7 47.80 ± 8.3 1.4 
24h CCl4 + Sp 0.79 ± 0.6 42.42 ± 6.5 11.45 ± 4.6 54.66 ± 3.9 2.34 ± 1.5 
 
33.58 ± 9.9 2.66 ± 2.4 38.58 ± 4.6 1.4 
48h CCl4 0.64 ± 0.2 36.51 ± 2.9 12.73 ± 2.0 49.87 ± 1.7 1.03 ± 0.7 28.38 ± 2.1 25.25 ± 10.6 5.43 ± 3.4 60.09 ± 4.2 0.8 
48h CCl4 + Sp 
 
52.09 ± 18.7 9.21 ± 1.9 61.30 ± 10.3 1.47 ± 0.8 13.53 ± 11.9 21.56 ± 7.4 
 
36.56 ± 6.7 1.7 
 
On the other hand, in the present study an 
increase of unsaturated fatty acid content was 
observed after CCl4 treatment. The largest increase 
was found in the group fed on diet without Sp at 48 h 
post-treatment (see Table 2). It is known that CCl4 
treatment releases trichloromethyl radicals, causing 
cellular injury, and lipid peroxidation (Torres-Duran et 
al., 2006); a second process involved in liver damage 
is the liberation of inflammatory mediators by 
macrophages and damaged hepatocytes, including 
nitric oxide; which is synthesized by both constitutive 
and inducible NO synthase; however, distinct roles has 
been proposed for nitric oxide concentrations in acute 
liver injury (Carnovale et al., 2000; Morio et al., 
2001).  
 
The antioxidant effect of dietary Sp is 
important for its hepatoprotective effects, keeping the  
saturated/unsaturated fatty acid ratio under minor 
changes (see Table 2). Higher concentrations of 
unsaturated fatty acids have been reported also in other 
conditions, in which there is liver damage, i.e., non-
alcoholic steatohepatitis (Ghebremeskel et al., 2002; 
Sato et al., 2004; Torres-Duran et al., 2006) and 
partial hepatectomy (Kishino et al., 2000).  
On the other hand, in brown adipose tissue, 
inhibition of the constitutive NO synthase by N-
nitro-L-arginine methyl ester (L-NAME) causes a 
significant increase in the unsaturation index (Saha et 
al., 1997), whereas Zheng et al. (2002) reported that in 
rats, hepatic steatosis induced by total parenteral 
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nutrition was protected by NO. Hence, it is plausible 
that the hepatoprotective action of dietary Sp in this 
study is related to its ability to increase the basal 
synthesis/release of NO, preventing the inducible 
overproduction (see Figure 3B), as reported for Sm 
specie (Paredes-Carbajal et al., 1997; Paredes-
Carbajal, 1998; Paredes-Carbajal et al., 2001). Nitric 
oxide production was only analyzed at 24 h post-
treatment because of the biological material was not 
enough at 48 h. 
This is also in accordance with previous 
studies that provide strong evidence of the beneficial 
use of natural antioxidants in the treatment of NAFLD. 
Recently, the prevalence of non-alcoholic fatty liver 
disease (NAFLD) has been increasing in the world. 
Non-alcoholic steatohepatitis (NASH), one kind of 
NAFLD, was first reported by Ludwig et al. (1997). It 
is considered that fatty liver progresses further to 
NASH. This condition is more difficult to treat than 
alcoholic steatohepatitis, and can lead to liver cirrhosis 
or cancer. The successful therapeutic application of Sm 
has already been reported by Ferreira Hermosillo et al. 
(2010).  
Sp contains high concentrations of 
antioxidants such as phycocyanine, xanthophylls, 
chlorophylls, carotenoids, and vitamin E, among 
others; therefore, it is possible that its protective 
effects may be related to these molecules (Kay, 1991; 
Chamorro et al., 2002). 
 
CONCLUSION  
Administration of Sp improves liver damage induced 
by CCl4 in Wistar rats, due to its antioxidant and 
hypolipidemic effects. It could be effective as a 
supplement in NASH treatment or hepatic diseases, 
since Sp has high concentrations of antioxidants.  
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